We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cell Culture Media Suppliers: Regulatory Considerations for Advanced Therapies
What are the regulatory challenges and opportunities that exist in media production for cell and gene therapies? In this webinar, Marlin Frechette, Corporate Compliance & Quality Officer, FUJIFILM Irvine Scientific, discusses the importance of choosing a media supplier that is prepared to partner with manufacturers through the raw materials qualification and regional regulatory approvals. Frechette also provides insight into how choosing a media supplier can assist manufacturers in addressing challenges and opportunities that transpire in bringing cell and gene therapies to market.
During this discussion, you will also learn:
- How long the regulatory approval process takes in different regions
- Unique raw material qualification processes
- The importance of safety and timelines for choosing a media supplier for clinical trials
- How the right media supplier helps with media costs
Watch the webinar recording to learn more about how FUJIFILM Irvine Scientific helps customers understand the many processes involved with the regulatory approval process.
Recent Posts
-
ALL IN on Innovation – Bringing New Life to CSCM-NX with the Day 0 Approach -
ALL IN on Innovation: The Next Generation of Embryo Culture Supplementation -
Interview: Bob Newman is ALL IN on Innovation -
Meet the Team: Interview with Jim O’Brien, Director of Commercial Operations, Medical Business Unit -
Meet the Team: Interview with Jennifer Brooks, Environmental Health and Safety (EHS) Manager
